Ads
related to: sglt2 inhibitors before and after cancer- Clinical Study Data
View Efficacy For A 2L HR+ HER2-
Metastatic Breast Cancer Treatment.
- Mechanism Of Action Info
See MOA & Treatment Info For A
2L HR+ HER2- aBC/mBC Treatment.
- HR+ HER2- mBC Therapy
Learn About A 2L Treatment
For Metastatic Breast Cancer.
- Dosing Info For HCPs
Dosing & Administration Info For A
2L HR+ HER2- aBC/mBC Treatment.
- Clinical Study Data
Search results
Results From The WOW.Com Content Network
Dapagliflozin is an example of an SGLT-2 inhibitor, it is a competitive, highly selective inhibitor of SGLT. It acts via selective and potent inhibition of SGLT-2, and its activity is based on each patient's underlying blood sugar control and kidney function. The results are decreased kidney reabsorption of glucose, glucosuria effect increases ...
Because sodium is absorbed at the same time as glucose via SGLT-2, the upregulation of SGLT-2 probably leads to development or maintenance of hypertension. In study where rats were given either ramipril or losartan, levels of SGLT-2 protein and mRNA were significantly reduced. In patients with diabetes, hypertension is a common problem so this ...
SGLT2 is a member of the sodium glucose cotransporter family, which are sodium-dependent glucose transport proteins. SGLT2 is the major cotransporter involved in glucose reabsorption in the kidney. [6] SGLT2 is located in the early proximal tubule, and is responsible for reabsorption of 80-90% of the glucose filtered by the kidney glomerulus. [7]
SGLT2 inhibitors, also called gliflozins, [14] are used in the treatment of type 2 diabetes. SGLT2 is only found in kidney tubules and in conjunction with SGLT1 resorbs glucose into the blood from the forming urine. By inhibiting SGLT2, and not targeting SGLT1, glucose is excreted which in turn lowers blood glucose levels.
SGLT-2 inhibitors—with brand names like Jardiance and Farxiga—are fundamentally different from GLP-1 agonists like popular weight-loss and diabetes drugs Wegovy and Ozempic, which increase ...
Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes. . Dapagliflozin, in addition to other SGLT2-inhibitors, was shown to reduce the rate of decline in kidney function and kidney failure in non-diabetic and type 2 diabetic adults when added to the existing treatment
Sotagliflozin, sold under the brand name Inpefa among others, is a medication used to reduce the risk of death due to heart failure. [1] It is an inhibitor of sodium-glucose cotransporter 1 and 2 (SGLT1/SGLT2 inhibitor). [1]
Steady-state concentrations are achieved after three to five weeks. The substance is most likely broken down by protease enzymes to small peptides and amino acids . [ 3 ] Being resistant to dipeptidyl peptidase-4 (DPP-4), [ 5 ] the enzyme that breaks down GLP-1, albiglutide has a biological half-life of five (four to seven) days, which is ...